Can Isatuximab (Isatuximab-irfc) be used alone?

Isatuximab (Isatuximab-irfc) is usually not used as a standalone drug but is used in combination with other anticancer drugs and treatments as part of a comprehensive treatment regimen for multiple myeloma (Multiple Myeloma, MM ). This is because multiple myeloma is a complex cancer that often requires multiple drug interventions to effectively control the disease.

The following are some common uses of isatuximab in the treatment of multiple myeloma:

1.With hormone therapy: Isatuximab is often used in combination with hormone therapy (such as dexamethasone). This combination treatment can reduce pain, slow tumor growth, and improve patients' symptoms.

2.With immunomodulators: Isatuximab can also be used with other immunomodulators such as rituximab (Lenalidomide) or carfilzomib (Carfilzomib). This combination treatment boosts the immune system and helps it better attack cancer cells.

3.With stem cell transplant: Stem cell transplant may be an effective treatment option for some patients with multiple myeloma. Isatuximab is sometimes used in treatment regimens before or after stem cell transplantation to help reduce or control tumor burden.

4.Maintenance therapy: In some cases, isatuximab can also be used as maintenance therapy, aiming to prolong the patient's remission period and reduce the recurrence of the disease.

It is important to emphasize that the use of isatuximab is usually determined by a medical professional based on the patient's specific situation and disease stage. Development of a treatment plan should be individualized, tailored to the patient's age, health, severity of symptoms, and other factors. Patients should always follow the advice of their medical professional, receive regular treatment, and participate in decisions about their treatment plan.